Air & Water Borne Diseases
Open Access

SARS-CoV-2 detection; RT-qPCR; Rapid diagnostic tests; CRISPR diagnostics; Wastewater surveillance; Point-of-care diagnostics; Saliva testing; Next-Generation Sequencing (NGS); Biosensors; Artificial Intelligence (AI) in diagnosis

Introduction

A critical review highlights the foundational role of reverse transcription-quantitative polymerase chain reaction (RT-qPCR) as the established gold standard for detecting SARS-CoV-2 and its various emerging variants. This essential method's principles, significant advantages, and inherent limitations are thoroughly discussed, consistently emphasizing its unparalleled high sensitivity and specificity, which are crucial attributes for accurate diagnosis and robust epidemiological surveillance [1].

A systematic review rigorously assesses the diagnostic accuracy of antigen-based rapid diagnostic tests for identifying SARS-CoV-2 infection. This assessment offers crucial insights into their performance across diverse settings, underscoring their considerable utility for large-scale mass screening efforts and the rapid identification of infectious individuals, particularly beneficial in symptomatic cases where quick results are paramount [2].

Innovative advancements in CRISPR-based diagnostic technologies for SARS-CoV-2 detection are extensively reviewed in a recent publication. This work underscores how these cutting-edge tools provide exceptional sensitivity, remarkable specificity, and crucial portability, positioning them as highly promising alternatives to more traditional methodologies for achieving rapid and decentralized testing capabilities [3].

The evolving landscape of wastewater surveillance for SARS-CoV-2 is thoroughly explored, detailing its various methodologies, inherent challenges, and significant potential as an early warning system for predicting community-level outbreaks. This non-invasive approach is highlighted for its paramount importance in broader public health monitoring strategies, offering an aggregated view of viral presence [4].

Focused research elaborates on the development and strategic deployment of point-of-care molecular diagnostic devices specifically designed for SARS-CoV-2. The discussion centers on how these rapid and highly portable platforms facilitate decentralized testing, thereby significantly reducing critical turnaround times and enabling earlier interventions, which are particularly advantageous in settings with limited resources [5].

A systematic review and meta-analysis meticulously evaluates the diagnostic accuracy of saliva samples for SARS-CoV-2 detection, directly comparing their efficacy to the conventional standard of nasopharyngeal swabs. The compelling conclusion indicates that saliva represents a viable, less invasive, and more patient-friendly alternative, demonstrating comparable sensitivity and making it highly suitable for widespread testing initiatives [6].

The extensive application of next-generation sequencing (NGS) is examined, not only for direct SARS-CoV-2 detection but also for its critical role in genomic surveillance. This review explicitly highlights NGS's powerful capability to precisely identify novel variants, accurately track transmission chains, and effectively inform public health strategies, solidifying its indispensable role in global pandemic responses [7].

Recent technological advancements in biosensor technology for the rapid and accurate detection of SARS-CoV-2 are comprehensively chronicled. This overview showcases diverse biosensor types, including electrochemical, optical, and mechanical platforms, illustrating their collective potential for delivering highly sensitive, specific, and portable diagnostic solutions, especially valuable for point-of-care applications [8].

A systematic review and meta-analysis meticulously assesses the diagnostic accuracy of various serological tests designed to detect SARS-CoV-2 antibodies. This research offers a comprehensive understanding of their sensitivity and specificity in accurately identifying past infections, which is fundamentally crucial for mapping population immunity and informing robust epidemiological studies [9].

Finally, the burgeoning role of Artificial Intelligence (AI), encompassing both machine learning and deep learning applications, in SARS-CoV-2 diagnosis is thoroughly investigated. This segment vividly showcases AI's immense potential in sophisticated medical image analysis, accurate prediction of disease progression, and overall enhancement of diagnostic accuracy and speed, presenting a powerful new tool for clinical decision-making processes [10].

Description

The detection of SARS-CoV-2 relies heavily on established molecular techniques and rapid diagnostic tools. Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) is consistently recognized as the gold standard for identifying the virus and its variants, lauded for its high sensitivity and specificity in diagnostic and surveillance efforts [1]. Complementing this, antigen-based rapid diagnostic tests offer a crucial alternative, particularly valuable for mass screening and the swift identification of infectious individuals, especially those exhibiting symptoms, thereby facilitating timely public health interventions [2].

Beyond traditional methods, newer technologies are advancing decentralized testing capabilities. CRISPR-based diagnostic technologies have emerged as promising alternatives, delivering high sensitivity, specificity, and portability, which makes them ideal for rapid, point-of-care applications [3]. Similarly, the development and deployment of point-of-care molecular diagnostic devices are vital, enabling rapid and portable testing outside conventional laboratory settings. These platforms significantly reduce turnaround times and support earlier intervention, which is especially critical in settings with limited resources [5].

Public health monitoring benefits from both novel surveillance methods and less invasive sampling techniques. Wastewater surveillance for SARS-CoV-2 has proven to be an effective non-invasive early warning system, detailing methodologies and challenges while highlighting its importance for community-level outbreak detection [4]. Furthermore, the investigation into saliva as an alternative to nasopharyngeal swabs for SARS-CoV-2 detection has shown promising results. A systematic review and meta-analysis confirmed that saliva offers a viable, less invasive, and patient-friendly option with comparable sensitivity, making it suitable for broader testing initiatives [6].

Advanced technologies are increasingly vital for both precise detection and comprehensive surveillance. Next-generation sequencing (NGS) plays an indispensable role, not only in direct SARS-CoV-2 detection but also in critical genomic surveillance. This capability allows for the identification of novel variants, tracking transmission chains, and informing strategic public health responses [7]. Additionally, recent advances in biosensor technology, encompassing electrochemical, optical, and mechanical types, are paving the way for highly sensitive, specific, and portable diagnostic solutions, further enhancing point-of-care applications [8].

Understanding population immunity and leveraging Artificial Intelligence (AI) are key components in the ongoing fight against SARS-CoV-2. Serological tests for SARS-CoV-2 antibodies are systematically assessed for their diagnostic accuracy, providing a comprehensive understanding of past infections and crucial insights for epidemiological studies and mapping population immunity [9]. Concurrently, Artificial Intelligence (AI), including machine learning and deep learning, is playing a growing role in SARS-CoV-2 diagnosis. AI's potential in analyzing medical images, predicting disease progression, and significantly enhancing the accuracy and speed of diagnostic processes offers a powerful tool for informed clinical decision-making [10].

Conclusion

The landscape of SARS-CoV-2 detection and surveillance has evolved significantly, encompassing a range of diagnostic technologies and public health monitoring strategies. Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) remains the gold standard, offering high sensitivity and specificity for viral detection and variant identification. Complementing RT-qPCR, antigen-based rapid diagnostic tests are crucial for mass screening and quick identification of infectious individuals, especially in symptomatic cases. Innovative approaches like CRISPR-based technologies provide highly sensitive, specific, and portable alternatives for rapid, decentralized testing. Beyond individual diagnostics, wastewater surveillance has emerged as an important non-invasive early warning system for community-level outbreaks. Point-of-care molecular diagnostic devices enable rapid, decentralized testing, which is vital for reducing turnaround times and facilitating early intervention, particularly in resource-limited settings. The utility of alternative sample types, such as saliva, offers a less invasive and patient-friendly option with comparable diagnostic accuracy to traditional nasopharyngeal swabs. Next-generation sequencing (NGS) is indispensable for both direct virus detection and crucial genomic surveillance, allowing for the identification of novel variants and tracking transmission chains. Advances in biosensor technology, including electrochemical, optical, and mechanical types, promise highly sensitive, specific, and portable diagnostic solutions for point-of-care applications. Serological tests for SARS-CoV-2 antibodies are critical for understanding past infections, population immunity, and epidemiological patterns. Finally, Artificial Intelligence (AI) and its subfields, machine learning and deep learning, are transforming diagnostics by enhancing the analysis of medical images and predicting disease progression, thereby improving accuracy and speed in clinical decision-making.

References

1. Md JU, Md JH, Md AI (2023 Jul 19) Rapid, Sensitive, and Specific Detection of SARS-CoV-2 and Variants by RT-qPCR: A Review.Diagnostics (Basel) 13:2418.

   Indexed at, Google Scholar, Crossref

2. M. APLD, J. D, A. A (2022 Jul 26) Antigen-based rapid diagnostic tests for diagnosing SARS-CoV-2 infection.Cochrane Database Syst Rev 7:CD013705.

   Indexed at, Google Scholar, Crossref

3. Ziyao Z, Jinglin L, Xinyu W (2021 Mar 12) CRISPR-Based Technologies for SARS-CoV-2 Detection and Diagnostics.ACS Infect Dis 7:477-488.

   Indexed at, Google Scholar, Crossref

4. Marwa M, Sherif E, Alaa EAE (2023 Feb 15) Wastewater surveillance for SARS-CoV-2: A review of approaches, challenges, and future directions.Sci Total Environ 859:160002.

   Indexed at, Google Scholar, Crossref

5. Andrew JC, Mark DT, Robert WE (2021 Jan) Point-of-care molecular diagnostics for SARS-CoV-2: a review.J R Soc Interface 18:20200832.

   Indexed at, Google Scholar, Crossref

6. Jessica MB, J. LMDS, Laura EVB (2021 Dec) Saliva as an alternative to nasopharyngeal swabs for SARS-CoV-2 detection: a systematic review and meta-analysis.EClinicalMedicine 42:101212.

   Indexed at, Google Scholar, Crossref

7. Manal N, Shada A, Shaikha A (2023 Apr) Next-generation sequencing for SARS-CoV-2 detection and genomic surveillance: A review.J Infect Public Health 16:533-543.

   Indexed at, Google Scholar, Crossref

8. Zhaowei L, Yaxuan W, Yan Z (2022 May 16) Recent advances in biosensors for rapid and accurate detection of SARS-CoV-2.Analyst 147:2066-2079.

   Indexed at, Google Scholar, Crossref

9. Jennifer BL, Saki FPK, Sarah LW (2021 Aug) Serological tests for SARS-CoV-2 antibodies: a systematic review and meta-analysis.Lancet Infect Dis 21:1103-1114.

   Indexed at, Google Scholar, Crossref

10. Negin G, Mohammad AM, Hamideh R (2022 Apr 19) Artificial Intelligence in SARS-CoV-2 Diagnosis: A Review of Machine Learning and Deep Learning Applications.Front Public Health 10:854556.

    Indexed at, Google Scholar, Crossref